These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response. Younossi ZM; McCullough AJ Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560 [TBL] [Abstract][Full Text] [Related]
16. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. Loria P; Lonardo A; Targher G Clin Sci (Lond); 2008 Jul; 115(1):1-12. PubMed ID: 19016656 [TBL] [Abstract][Full Text] [Related]
17. [Metabolic syndrome and NAFLD/NASH]. Tamura Y; Sato F; Kawamori R Nihon Rinsho; 2006 Dec; 64 Suppl 9():449-52. PubMed ID: 17458261 [No Abstract] [Full Text] [Related]
18. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098 [TBL] [Abstract][Full Text] [Related]
19. How should we manage patients with non-alcoholic fatty liver disease in 2007? Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC; J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632 [TBL] [Abstract][Full Text] [Related]